These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


200 related items for PubMed ID: 3544380

  • 1. Results of conversion from cyclosporine to azathioprine in cadaveric renal transplantation.
    Gonwa TA, Nghiem DD, Schulak JA, Corry RJ.
    Transplantation; 1987 Feb; 43(2):225-8. PubMed ID: 3544380
    [Abstract] [Full Text] [Related]

  • 2. Renal allograft biopsy and conversion of cyclosporine to azathioprine.
    Shen SY, Weir MR, Coughlin TR.
    Transplantation; 1989 Feb; 47(2):223-9. PubMed ID: 2645702
    [Abstract] [Full Text] [Related]

  • 3. Amelioration of chronic renal allograft dysfunction in cyclosporine-treated patients by addition of azathioprine.
    Rocher LL, Hodgson RJ, Merion RM, Swartz RD, Keavey S, Turcotte JG, Campbell DA.
    Transplantation; 1989 Feb; 47(2):249-54. PubMed ID: 2645707
    [Abstract] [Full Text] [Related]

  • 4. Results of the Minnesota randomized prospective trial of cyclosporine versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.
    Sutherland DE, Fryd DS, Strand MH, Canafax DM, Ascher NL, Payne WD, Simmons RL, Najarian JS.
    Am J Kidney Dis; 1985 Jun; 5(6):318-27. PubMed ID: 3893106
    [Abstract] [Full Text] [Related]

  • 5. A randomized trial comparing cyclosporine with antilymphoblast-globulin-azathioprine for renal allograft recipients. Results at 2 1/2-6 years.
    Johnson CP, Simmons RL, Sutherland DE, Canafax DM, Ascher NL, Payne WD, Flick B, Najarian JS, Fryd DS.
    Transplantation; 1988 Feb; 45(2):380-5. PubMed ID: 3278431
    [Abstract] [Full Text] [Related]

  • 6. Evidence that addition of azathioprine improves renal function in cyclosporine-treated patients with allograft dysfunction.
    Pascual J, Marcén R, Orofino L, Quereda C, Mampaso F, Liaño F, Ortuño J.
    Transplantation; 1991 Aug; 52(2):276-9. PubMed ID: 1871800
    [Abstract] [Full Text] [Related]

  • 7. Conversion from cyclosporine to azathioprine improves renal function without increased risk of graft failure.
    Maddux MS, Veremis SA, Pollak R, Mozes MF.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2007-9. PubMed ID: 3079066
    [Abstract] [Full Text] [Related]

  • 8. Elective conversion from cyclosporine to azathioprine in recipients with stable renal function 6 months after kidney transplantation.
    Thistlethwaite JR, Haag BW, Jones KW, Stuart JK, Stuart FP.
    Hum Immunol; 1985 Nov; 14(3):314-23. PubMed ID: 3902749
    [Abstract] [Full Text] [Related]

  • 9. HLA-identical renal transplants: impact of cyclosporine on intermediate-term survival and renal function.
    Sumrani N, Delaney V, Ding ZK, Butt K, Hong J.
    Am J Kidney Dis; 1990 Nov; 16(5):417-22. PubMed ID: 2239931
    [Abstract] [Full Text] [Related]

  • 10. Low-dose cyclosporine for cadaveric renal transplantation.
    Vanderwerf BA, Serota AI.
    Transplantation; 1988 Feb; 45(2):320-3. PubMed ID: 3278422
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Post-transplant acute renal failure in cadaver renal recipients treated with cyclosporine.
    Hall BM, Tiller DJ, Duggin GG, Horvath JS, Farnsworth A, May J, Johnson JR, Sheil AG.
    Kidney Int; 1985 Aug; 28(2):178-86. PubMed ID: 3914572
    [Abstract] [Full Text] [Related]

  • 14. Cyclosporine toxicity: the effect of combined therapy using cyclosporine, azathioprine, and prednisone.
    Lorber MI, Flechner SM, Van Buren CT, Sorensen K, Kerman RH, Kahan BD.
    Am J Kidney Dis; 1987 Jun; 9(6):476-84. PubMed ID: 3296744
    [Abstract] [Full Text] [Related]

  • 15. An increased incidence of late acute rejection episodes in cadaver renal allograft recipients given azathioprine, cyclosporine, and prednisone.
    Wrenshall LE, Matas AJ, Canafax DM, Min DI, Sibley RJ, Dunn DL, Payne WD, Sutherland DE, Najarian JS.
    Transplantation; 1990 Aug; 50(2):233-7. PubMed ID: 2382291
    [Abstract] [Full Text] [Related]

  • 16. Cadaveric renal transplantation under cyclosporine-steroid therapy.
    Rosenthal JT, Hakala TR, Iwatsuki S, Shaw BW, Starzl TE.
    Surg Gynecol Obstet; 1983 Oct; 157(4):309-15. PubMed ID: 6353643
    [Abstract] [Full Text] [Related]

  • 17. Sequential use of Minnesota antilymphoblast globulin and cyclosporine in cadaveric renal transplantation.
    Kupin WL, Venkatachalam KK, Oh HK, Dienst S, Levin NW.
    Transplantation; 1985 Dec; 40(6):601-4. PubMed ID: 3907029
    [Abstract] [Full Text] [Related]

  • 18. Effect of early cyclosporine levels on kidney allograft rejection.
    Johnson EM, Canafax DM, Gillingham KJ, Humar A, Pandian K, Kerr SR, Najarian JS, Matas AJ.
    Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
    [Abstract] [Full Text] [Related]

  • 19. Early graft function in primary and regraft recipients of paired cadaveric kidneys.
    Jaklitsch MT, Deierhoi MH, Hudson S, Barber WH, Barger BO, Phillips MG, Diethelm AG.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1274-5. PubMed ID: 2652421
    [No Abstract] [Full Text] [Related]

  • 20. The effects of delayed function on recipients of cadaver renal allografts. A study of 158 patients randomized to cyclosporine or ALG-azathioprine.
    Canafax DM, Torres A, Fryd DS, Heil JE, Strand MH, Ascher NL, Payne WD, Sutherland DE, Simmons RL, Najarian JS.
    Transplantation; 1986 Feb; 41(2):177-81. PubMed ID: 3511581
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.